Literature DB >> 15844284

Part 2: Patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing.

Paul Hewitson1, Joan Austoker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15844284     DOI： 10.1111/j.1464-410x.2005.05440.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  9 in total

1.  Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT).

Authors:  Maaike J Denters; Marije Deutekom; Marie-Louise Essink-Bot; Patrick M Bossuyt; Paul Fockens; Evelien Dekker
Journal:  Health Expect       Date:  2013-02-25       Impact factor: 3.377

2.  Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer.

Authors:  J C Faivre; V Adam; V Block; M Metzger; J Salleron; S Dauchy
Journal:  Support Care Cancer       Date:  2017-06-08       Impact factor: 3.603

3.  Developing a conceptual map of patient information needs in prostate cancer screening.

Authors:  Roxana M Maffei
Journal:  NI 2012 (2012)       Date:  2012-06-23

4.  [What do men between 50 and 70 know about the effectiveness, the benefits, and the risks of prostate cancer screening?].

Authors:  Mireia Fàbregas Escurriola; Laia Guix Font; Rosa Aragonès Forès; Josep Casajuana Brunet; Mar Ballester Torrens
Journal:  Aten Primaria       Date:  2008-07       Impact factor: 1.137

Review 5.  Psychological aspects of PSA testing.

Authors:  Riccardo G V Torta; Jacopo Munari
Journal:  Nat Rev Urol       Date:  2009-09       Impact factor: 14.432

6.  Ethical issues in epidemiologic research and public health practice.

Authors:  Steven S Coughlin
Journal:  Emerg Themes Epidemiol       Date:  2006-10-03

7.  The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk.

Authors:  J Melia; D Dearnaley; S Moss; L Johns; P Coulson; C Moynihan; J Sweetman; M C Parkinson; R Eeles; M Watson
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

8.  Biomarkers, the molecular gaze and the transformation of cancer survivorship.

Authors:  Kirsten Bell
Journal:  Biosocieties       Date:  2013-06

9.  Education concerning carcinoma of prostate and its early detection.

Authors:  Sławomir Dutkiewcz; Sylwia Jędrzejewska
Journal:  Cent European J Urol       Date:  2011-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.